The Role of the Clinical Pharmacist on the Health Outcomes of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)

References

• Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2020 Report). Global Initiative for Chronic Obstructive Lung Disease, Inc; 2020.
   Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. PubMed PMID: 29650248. doi:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• Bai CX, Cai BQ, Feng YL. Chinese Expert Consensus on the diagnosis and treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Int J Respir. 2017;37:1042–1057.
   Google Scholar
• Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. 2003;163(10):1180–1186. PubMed PMID: 12767954. doi:10.1001/archinte.163.10.1180
   PubMed Web of Science ®Google Scholar
• Abdulsalim S, Unnikrishnan MK, Manu MK, Alrasheedy AA, Godman B, Morisky DE. Structured pharmacist-led intervention programme to improve medication adherence in COPD patients: a randomized traditionalled study. Res Social Adm Pharm. 2018;14(10):909–914. PubMed PMID: 29104008. doi:10.1016/j.sapharm.2017.10.008
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 2016;387(10015):251–272. PubMed PMID: 26510778. doi:10.1016/S0140-6736(15)00551-6
   PubMed Web of Science ®Google Scholar
• Dang-Tan T, Ismaila A, Zhang S, Zarotsky V, Bernauer M. Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review. BMC Res Notes. 2015;8:464. PubMed PMID: 26391471; PubMed Central PMCID: PMCPMC4578756. doi:10.1186/s13104-015-1427-y
   PubMedGoogle Scholar
• Chen X, Wang N, Chen Y, Xiao T, Fu C, Xu B. Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four cities. Int J Chron Obstruct Pulmon Dis. 2016;11:2625–2632. PubMed PMID: 27799761; PubMed Central PMCID: PMCPMC5079691. doi:10.2147/COPD.S118523
   PubMed Web of Science ®Google Scholar
• Wang Y, Ghoshal AG, Bin Abdul Muttalif AR, et al. Quality of life and economic burden of respiratory disease in Asia-pacific-Asia-pacific burden of respiratory diseases study. Value Health Reg Issues. 2016;9:72–77. PubMed PMID: 27881264. doi:10.1016/j.vhri.2015.11.004
   PubMedGoogle Scholar
• Li J, Feng R, Cui Y. Analysis of the economic burden of medical treatment of COPD patients in tertiary hospitals in China. China Health Econ. 2015;34(9):66–68.
   Google Scholar
• Anees UR, Ahmad Hassali MA, Muhammad SA, et al. The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature. Expert Rev Pharmacoecon Outcomes Res. 2020;20(6):661–672. PubMed PMID: 31596632. doi:10.1080/14737167.2020.1678385
   PubMed Web of Science ®Google Scholar
• Croce D, Lazzarin A, Rizzardini G, et al. HIV clinical pathway: a new approach to combine guidelines and sustainability of anti-retroviral treatment in Italy. PLoS One. 2016;11(12):e0168399. PubMed PMID: 28030621; PubMed Central PMCID: PMCPMC5193418. doi:10.1371/journal.pone.0168399
   PubMed Web of Science ®Google Scholar
• Soobrian J, Tyrrell A, Li C. Using a disease pathway management approach to improve the quality of breast cancer care in Ontario. J Clin Oncol. 2016;34(7_suppl):109. doi:10.1200/jco.2016.34.7_suppl.109
   Web of Science ®Google Scholar
• Panagiotidis I, Christoulas D, Terpos E. Inhibition of receptor activator of nuclear factor kappa-B ligand pathway for the management of aggressive osteosarcoma. Ann Transl Med. 2016;4(24):510. PubMed PMID: 28149872; PubMed Central PMCID: PMCPMC5233538 interest to declare. doi:10.21037/atm.2016.11.75
   PubMed Web of Science ®Google Scholar
• Killoran J, Balboni TA, Krishnan MS, Krishnan MS, Taylor A, Martin NE. Development and implementation of a clinical pathway for radiation of bone metastases on a palliative radiation oncology service. J Clin Oncol. 2016;34(26_suppl):170. doi:10.1200/jco.2016.34.26_suppl.170
   Web of Science ®Google Scholar
• Zhang Z. Clinical effect of pharmacists participating in the clinical path of chronic obstructive pulmonary disease. J Clin Rational Drug Use. 2018;11(24):16–18.
   Google Scholar
• Madran B, Keske S, Uzun S, et al. Effectiveness of clinical pathway for upper respiratory tract infections in emergency department. Int J Infect Dis. 2019;83:154–159. PubMed PMID: 31051280. doi:10.1016/j.ijid.2019.04.022
   PubMed Web of Science ®Google Scholar
• Tarin T, Feifer A, Kimm S, et al. Impact of a common clinical pathway on length of hospital stay in patients undergoing open and minimally invasive kidney surgery. J Urol. 2014;191(5):1225–1230. PubMed PMID: 24270130. doi:10.1016/j.juro.2013.11.030
   PubMed Web of Science ®Google Scholar
• DeLaroche AM, Sivaswamy L, Farooqi A, Kannikeswaran N. Pediatric stroke clinical pathway improves the time to diagnosis in an emergency department. Pediatr Neurol. 2016;65:39–44. PubMed PMID: 27743748. doi:10.1016/j.pediatrneurol.2016.09.005
   PubMed Web of Science ®Google Scholar
• Nishimura K, Yasui M, Nishimura T, Oga T. Clinical pathway for acute exacerbations of chronic obstructive pulmonary disease: method development and five years of experience. Int J Chron Obstruct Pulmon Dis. 2011;6:365–372. PubMed PMID: 21760723; PubMed Central PMCID: PMCPMC3133508. doi:10.2147/COPD.S20423
   PubMed Web of Science ®Google Scholar
• Plishka CT, Rotter T, Penz ED, et al. Effects of clinical pathways for COPD on patient, professional, and systems outcomes: a systematic review. Chest. 2019;156(5):864–877. PubMed PMID: 31150639. doi:10.1016/j.chest.2019.04.131
   PubMed Web of Science ®Google Scholar
• Ban A, Ismail A, Harun R, Abdul Rahman A, Sulung S, Syed Mohamed A. Impact of clinical pathway on clinical outcomes in the management of COPD exacerbation. BMC Pulm Med. 2012;12:27. PubMed PMID: 22726610; PubMed Central PMCID: PMCPMC3479064. doi:10.1186/1471-2466-12-27
   PubMed Web of Science ®Google Scholar
• Fang Z. Analysis of the application status of clinical path management mode in hospital management. China Med Herald. 2017;14(10):166–169.
   Google Scholar
• Huang X. Development and current status of clinical path management. Chin Med Records. 2014;2014(11):22–24.
   Google Scholar
• Hudd TR. Emerging role of pharmacists in managing patients with chronic obstructive pulmonary disease. Am J Health Syst Pharm. 2020;77(19):1625–1630. PubMed PMID: 32699897; PubMed Central PMCID: PMCPMC7499078. doi:10.1093/ajhp/zxaa216
   PubMed Web of Science ®Google Scholar
• Sun Z. Medical Statistics. 3rd ed. Beijing: People’s Medical Publishing House; 2010.
   Google Scholar
• Zhang HX, Li X, Huo HQ, Liang P, Zhang JP, Ge WH. Pharmacist interventions for prophylactic antibiotic use in urological inpatients undergoing clean or clean-contaminated operations in a Chinese hospital. PLoS One. 2014;9(2):e88971. PubMed PMID: 24586465; PubMed Central PMCID: PMCPMC3934870. doi:10.1371/journal.pone.0088971
   PubMed Web of Science ®Google Scholar
• Wang B, Miao Q. Research progress of gender differences in chronic obstructive pulmonary disease. Chin J Clin. 2013;7(12):5564–5567.
   Google Scholar
• Han R, Zhao Z. Expert consensus on Chinese pharmaceutical service standards and charges. Drug Eval. 2016;13(14):8–15.
   Google Scholar
• Zhong H, Ni XJ, Cui M, Liu XY. Evaluation of pharmacist care for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Clin Pharm. 2014;36(6):1230–1240. PubMed PMID: 25330865. doi:10.1007/s11096-014-0024-9
   PubMed Web of Science ®Google Scholar
• Tommelein E, Mehuys E, Van Hees T, et al. Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized traditionalled trial. Br J Clin Pharmacol. 2014;77(5):756–766. PubMed PMID: 24117908; PubMed Central PMCID: PMCPMC4004396. doi:10.1111/bcp.12242
   PubMed Web of Science ®Google Scholar
• van Boven JF, Stuurman-Bieze AG, Hiddink EG, Postma MJ, Vegter S. Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence. J Manag Care Spec Pharm. 2014;20(8):786–792. PubMed PMID: 25062071. doi:10.18553/jmcp.2014.20.8.786
   PubMed Web of Science ®Google Scholar
• Gillespie U, Alassaad A, Henrohn D, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized traditionalled trial. Arch Intern Med. 2009;169(9):894–900. PubMed PMID: 19433702. doi:10.1001/archinternmed.2009.71
   PubMedGoogle Scholar
• Marin Armero A, Calleja Hernandez MA, Perez-Vicente S, Martinez-Martinez F. Pharmaceutical care in smoking cessation. Patient Prefer Adherence. 2015;9:209–215. PubMed PMID: 25678779; PubMed Central PMCID: PMCPMC4319467. doi:10.2147/PPA.S67707
   PubMed Web of Science ®Google Scholar
• Hohl CM, Partovi N, Ghement I, et al. Impact of early in-hospital medication review by clinical pharmacists on health services utilization. PLoS One. 2017;12(2):e0170495. PubMed PMID: 28192477; PubMed Central PMCID: PMCPMC5305222. doi:10.1371/journal.pone.0170495
   PubMed Web of Science ®Google Scholar
• Smith AL, Palmer V, Farhat N. Hospital-based clinical pharmacy services to improve ambulatory management of chronic obstructive pulmonary disease. J Pharm Technol. 2017;33(1):8–14. doi:10.1177/8755122516675635
   Web of Science ®Google Scholar
• Nguyen TS, Nguyen TLH, Van Pham TT, Hua S, Ngo QC, Li SC. Pharmacists’ training to improve inhaler technique of patients with COPD in Vietnam. Int J Chron Obstruct Pulmon Dis. 2018;13:1863–1872. PubMed PMID: 29928117; PubMed Central PMCID: PMCPMC6001739. doi:10.2147/COPD.S163826
   PubMed Web of Science ®Google Scholar